Bill Promoting Daily Contraceptive OTC Switch Prompts Criticism As Affordable Care Act Attack
This article was originally published in The Tan Sheet
Critics say the Allowing Greater Access to Safe and Effective Contraception Act, to expedite reviews of OTC switch applications for daily oral contraceptives and waive sponsors’ filing fees, would circumvent the Affordable Care Act requirement for health insurance to cover birth control without co-pays.
You may also be interested in...
A new paradigm for nonprescription approvals could eliminate the risk of self-selecting a birth control drug, with some contraindications might likely not apparent, by having pharmacists provide counseling and screening or having women use a self-assessment tool with a standard algorithm.
White House, Democrat majority in Congress and likely next FTC chair support the agency wielding the authority, says advertising law attorney Holly Melton. Supreme Court, though, likely will rule in pending cases that a strict reading of an FTC regulation doesn’t grant monetary penalty authority.
Perrigo is latest consumer health firm to note substantially slower flu rates slammed OTC drug sales during 2020 fourth quarter. Its total cough/cold product sales for the year were off $63m on decreases of $34m in the Americas and $29m in its international markets.